Related Experiment Video
Updated: Jul 5, 2026
Culture of myeloid dendritic cells from bone marrow precursors
Published on: July 25, 2008
[A preliminary study on the biological characteristics and function of exosomes derived from dendritic cells]
Ya-na Ren1, Hua-hua Fan, Li Gao
1Molecular Immunology Laboratory of East China Normal University, Blood Engineering Laboratory of Shanghai Blood Center, Shanghai 200051, China.
Insights
Researchers developed a method to isolate exosomes from dendritic cells (DCs) for cancer immunotherapy. These exosomes enhance T cell proliferation and antitumor immunity, offering a promising new approach to cancer treatment.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Dendritic cells (DCs) are crucial for initiating immune responses.
- Exosomes are small vesicles secreted by cells, involved in intercellular communication.
- Understanding exosome function in DCs is key for developing novel immunotherapies.
Purpose of the Study:
- To establish a method for isolating exosomes from dendritic cells (DCs).
- To analyze the biological characteristics and function of these exosomes in antitumor immunity.
- To evaluate the potential of DC-derived exosomes in cancer immunotherapy.
Main Methods:
- Immature and mature DCs were generated from human peripheral blood mononuclear cells.
- Exosomes were isolated from DCs using ultracentrifugation and ultrafiltration.
- Exosome characteristics (size, surface molecules) and function (T cell proliferation, IFN-gamma expression, cytotoxicity) were analyzed.
Main Results:
- Exosomes were characterized as vesicles with an average diameter of 72.3 nm, expressing key surface molecules (CD80, CD86, HLA-DR, FasL, CD54).
- Exosomes from mature DCs showed increased CD80 and decreased MFG-E8 compared to immature DC exosomes.
- Mature DC exosomes significantly enhanced antigen-specific T cell proliferation, IFN-gamma expression, and cytotoxicity against tumor cells in vitro.
Conclusions:
- A simple and rapid method for isolating and analyzing DC-derived exosomes was successfully established.
- DC-derived exosomes possess the ability to induce antitumor immune responses.
- These findings highlight the potential of DC-derived exosomes as a therapeutic strategy for cancer treatment.
Objective:
To establish a method for isolating exosomes from dendritic cells (DC), and to analyse its biological characteristics and function in antitumor immunity.
Methods:
Immature DCs (im-DC) from human peripheral blood mononuclear cells were loaded with the antigen of K562 tumor cells, then exosomes were secreted from imDC and lipopolysaccharide (LPS) induced mature DC (mDC). The exosomes from imDC and mDC were isolated separately by ultracentrifugation and ultrafiltration. The exosomes diameter was determined, their profile was observed by electron microscope, and the surface molecules were detected by Western blot. To analyse the effect of exosomes on antitumor immunity, the proliferation, IFN-gamma expression, CD69 up-regulation and cytotoxicity of antigen-specific T cells were measured.
Results:
Exosomes were small flattened sphere vesicles with an average diameter of 72.3 nm and expressed CD80, CD86, HLA-DR, FasL, CD54 and MFG-E8 molecules. As compared to immature exosomes, exosomes from mDC were proved to express more CD80 and less MFG-E8, to be more potent for inducing antigen-specific T cells proliferation and immunity respond in vitro: at its optimum concentration, the absorption value of T cell proliferation test was 0.50 +/- 0.01, CD69 was up-regulated and (13.4 +/- 5.8)% of T cells was in proliferating, (22.8 +/-2.4)% of T cells expressed IFN-gamma, and (21.3 +/-8.6)% of tumor cells were killed.
Conclusion:
A simple and quick method to isolate and analyse exosomes is established. The exosomes can induce antitumor immunity respond.
